EBS announcements Emergent Biosolutions, Inc. announcements and dividends declared NYSE

Emergent Biosolutions, Inc. Complete list of announcements declared & dividend announcements by Emergent Biosolutions, Inc. EBS

Emergent Biosolutions, Inc. EBS listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Emergent Biosolutions, Inc. EBS

Emergent Biosolutions (EBS) Reports Q2 Loss, Tops Revenue Estimates
Emergent Biosolutions (EBS) came out with a quarterly loss of .06 per share versus the Zacks Consensus Estimate of a loss of [CO].98. This compares to loss of [CO].86 per share a year ago. These figures are adjusted for non-recurrin
Announcement as on 08 August 2023

Emergent Biosolutions (EBS) Reports Q2 Loss, Tops Revenue Estimates
Emergent Biosolutions (EBS) came out with a quarterly loss of .06 per share versus the Zacks Consensus Estimate of a loss of [CO].98. This compares to loss of [CO].86 per share a year ago. These figures are adjusted for non-recurrin
Announcement as on 08 August 2023

Emergent BioSolutions shares rally as Narcan gets over-the-counter OK from FDA
Emergent BioSolutions shares rally as Narcan gets over-the-counter OK from FDA
Announcement as on 29 March 2023

Why Emergent BioSolutions Stock Tumbled by Almost 12% Today
What happened Emergent BioSolutions (NYSE: EBS) probably wishes it had stayed in bed on Tuesday. The company's stock declined by nearly 12% that day, following its release of quarterly results that fell well short of expectations on the bottom line.
Announcement as on 28 February 2023

Emergent Biosolutions (EBS) Moves 12.5% Higher: Will This Strength Last?
Emergent Biosolutions EBS shares ended the last trading session 12.5% higher at .92. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 0.5% gain over the past fo
Announcement as on 16 February 2023

Announcements by Emergent Biosolutions, Inc. first page | Next page | Prev page |

EBS Emergent Biosolutions, Inc. current price & indicator signals

Moving Averages for Emergent Biosolutions, Inc.

  • 5Day Average: 7.24
  • 12Day Average: 7.94
  • 20Day Average: 8.85
  • 50Day Average: 9.51
  • 100Day Average: 9.38
  • 150Day Average: 9.04
  • 200Day Average: 8.76

EBS Indicators & signals

Indicator MACD (12,26,9)

7.95, 8.74, -0.6
Indicator MACD is in negative zone

Indicator ADX (14)

46.15, 12.07, 32.76
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 41
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of EBS Emergent Biosolutions, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
28 Fri Feb 2025 7.48 6.96 to 7.50 5.95% 0.67 times
27 Thu Feb 2025 7.06 7.05 to 7.49 -2.89% 0.65 times
26 Wed Feb 2025 7.27 7.11 to 7.34 0.83% 0.47 times
25 Tue Feb 2025 7.21 6.96 to 7.29 0.7% 0.73 times
24 Mon Feb 2025 7.16 7.06 to 7.71 -7.13% 1.05 times
21 Fri Feb 2025 7.71 7.62 to 7.90 -1.66% 0.86 times
20 Thu Feb 2025 7.84 7.84 to 8.30 -1.63% 0.78 times
19 Wed Feb 2025 7.97 7.57 to 8.37 0% 1.87 times
19 Wed Feb 2025 7.97 7.57 to 8.37 -4.44% 1.87 times
18 Tue Feb 2025 8.34 8.33 to 9.96 -14.2% 1.27 times
14 Fri Feb 2025 9.72 9.33 to 9.73 2.32% 0.46 times
13 Thu Feb 2025 9.50 9.11 to 9.59 0.32% 0.7 times

Videos related to: EBS announcements Emergent Biosolutions, Inc. announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

EBS announcements Emergent Biosolutions, Inc. announcements and dividends declared NYSE

 

Back to top